Patents by Inventor Eider San Sebastián Larzabal

Eider San Sebastián Larzabal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160122340
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer hematological malignancy, proliferative diseases, neurological disorders and immunological disorders.
    Type: Application
    Filed: May 9, 2014
    Publication date: May 5, 2016
    Inventors: Fernando Pedro COSSÍO MORA, Yosu Ion VARA SALAZAR, María del Carmen MASDEU MARGALEF, María Remedios ALCALÁ CAFFARENA, Sergio VILLAFRUELA CÁNEVA, Dorleta OTAEGUI ANSA, Eneko ALDABA ARÉVALO, Aizpea ZUBIA OLASCOAGA, Eider SAN SEBASTIÁN LARZABAL
  • Publication number: 20150336889
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer hematological malignancy, proliferative diseases, genetic diseases, neurological disorders and immunological disorders.
    Type: Application
    Filed: November 7, 2013
    Publication date: November 26, 2015
    Inventors: Fernando Pedro COSSÍO MORA, Yosu Ion VARA SALAZAR, María del Carmen MASDEU MARGALEF, María Remedios ALCALÁ CAFFARENA, Sergio VILLAFRUELA CÁNEVA, Dorleta OTAEGUI ANSA, Eneko ALDABA ARÉVALO, Eider SAN SEBASTIÁN LARZABAL, Aizpea ZUBIA OLASCOAGA
  • Publication number: 20150038545
    Abstract: The present invention refers to compounds derived from hydroxyphenyl 1H-pyrrole rings, which have the following formula (I): as well as to the procedure for their preparation, pharmaceutical compositions comprising the same and the use thereof for the treatment and/or prevention of a condition mediated by histone deacetylase such as cancer, hematological malignancies, autoimmune diseases, inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases and psychiatric disorders, cardiovascular diseases, endocrine and metabolic disorders, by inhibiting histone deacetylases and the therapeutic use of biological processes related to the mentioned inhibition.
    Type: Application
    Filed: April 4, 2012
    Publication date: February 5, 2015
    Applicants: UNIVERSIDAD DEL PAÍS VASCO, IKERCHEM, S.L.
    Inventors: Fernando Pedro Cossío Mora, Yosu Ion Vara Salazar, Eider San Sebastián Larzabal, Dorleta Otaegui Ansa, María del Carmen Masdeu Margalef, Eneko Aldaba Arévalo, Maialen Aginagalde Unanue, Sergio Villafruela Cáneva, María Remedios Alcalá Caffarena, Aizpea ZUubia Olascoaga
  • Patent number: 8835659
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer, aging related diseases or processes, diabetes and neurodegenerative diseases.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: September 16, 2014
    Assignees: Ikerchem, S.L., Universidad del Pais Vasco
    Inventors: Fernando Pedro Cossio Mora, Leire Lidia Arias Echeverría, Yosu Ion Vara Zalazar, Eneko Aldaba Arévalo, Eider San Sebastián Larzabal, Aizpea Zubia Olascoaga
  • Publication number: 20130217730
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer, aging related diseases or processes, diabetes and neurodegenerative diseases.
    Type: Application
    Filed: May 10, 2011
    Publication date: August 22, 2013
    Applicant: IKERCHEM, S.L.
    Inventors: Fernando Pedro Cossio Mora, Leire Lidia Arias Echeverría, Yosu Ion Vara Zalazar, Eneko Aldaba Arévalo, Eider San Sebastián Larzabal, Aizpea Zubia Olascoaga
  • Patent number: 7943660
    Abstract: The invention relates to the treatment of disorders or diseases mediated by LFA-1/ICAM-1 molecular interaction. This is based on the use of novel chemical compounds capable of inhibiting said interaction, and more particularly, to pharmaceutical compositions containing these compounds.
    Type: Grant
    Filed: November 14, 2005
    Date of Patent: May 17, 2011
    Assignee: Dominion Pharmakine S.L.
    Inventors: Natalia Gallot Escobal, Fernando Vidal Vanaclocha, Fernando Pedro Cossio Mora, Miren Lorea Mendoza Arteche, Aizpea Zubia Olascoaga, Maria Valcarcel Cuesta, Yosu Ion Vara Salazar, Miren Sorne Solaun Aguirre, Jose Javier Lopez Pestana, Eider San Sebastian Larzabal
  • Publication number: 20080249157
    Abstract: The invention relates to the treatment of disorders or diseases mediated by LFA-1/ICAM-1 molecular interaction. This is based on the use of novel chemical compounds capable of inhibiting said interaction, and more particularly, to pharmaceutical compositions containing these compounds.
    Type: Application
    Filed: November 14, 2005
    Publication date: October 9, 2008
    Applicants: DOMINION PHARMAKINE S.L., UNIVERSIDAD DEL PAIS VASCO
    Inventors: Fernando Pedro Cossio Mora, Eider San Sebastian Larzabal, Miren Lorea Mendoza Arteche, Aizpea Zubia Olascoaga, Maria Valcarcel Cuesta, Yosu Ion Vara Salazar, Miren Sorne Solaun Aguirre, Jose Javier Lopez Pestana, Natalia Gallot Escobal, Fernando Vidal Vanaclocha